It has the advantage of low toxicity and few vestigital . Nosiheptide was approved as the third new veterinary new medicine in 1998 in China .

由于诺西肽促进 动物 肠道 吸收及 动物 生长并具有毒性低，在 动物 体内 残留少的优点，我国于1998年将其批准为三类新兽药。